Search Results - "Irã"

Review about Santiago Molina García and Ángel Gómez Moreno: Myths and ideologies in the schooling of mentally deficient children by Alfredo Alcina Madueño

Connect to this object online.

Pan-Cancer Analysis Reveals Alternative Splicing Characteristics Associated With Immune-Related Adverse Events Elicited by Checkpoint Immunotherapy by Xiujing He, Jing Yu, Hubing Shi

Connect to this object online.

2 Immune related adverse events in endometrial cancer: a biomarker for treatment efficacy? by Vinita Popat, Steven Blaine Holloway, Jayanthi Lea

Connect to this object online.

Association between immune-related adverse events and immunotherapy efficacy in non-small-cell lung cancer: a meta-analysis by Li Lin, Yu Liu, Chen Chen, Anhua Wei, Wei Li

Connect to this object online.

Characterization and Prognostic Significance of Cutaneous Immune-Related Adverse Events in Indian Patients on Immune Checkpoint Inhibitor Therapy by Prasanna Duraisamy, Vinitha Panicker, Wesley Jose

Connect to this object online.

PD-1 inhibitor-based adverse events in solid tumors: A retrospective real-world study by Guili Huang, Songqing Liu, Jie Dong, Xin Xi, Rui Kong, Wenjun Li, Qian Du

Connect to this object online.

Safety and efficacy of immune checkpoint inhibitors in advanced cancer patients with autoimmune disease: A meta-analysis by Qi Cai, Geng-wei Huo, Fu-yi Zhu, Ping Yue, Dong-qi Yuan, Peng Chen

Connect to this object online.

Current landscape and tailored management of immune-related adverse events by Wenhui Liu, Wenhui Liu, Zhiying Luo, Zhiying Luo, Yiping Liu, Yiping Liu, Bao Sun, Bao Sun, Bao Sun

Connect to this object online.

Single Institution Experience with Immune Checkpoint Inhibitors in Vulvar and Vaginal Melanomas by Amrita Ladwa, Omar Elghawy, Varinder Kaur

Connect to this object online.

Predictive value of near-term prediction models for severe immune-related adverse events in malignant tumor PD-1 inhibitor therapy by Yunyi Du, Ying Zhang, Wenqi Zhao, Yuexiang Zhang, Fei Su, Xiaoling Zhang, Weiling Li, Wenqing Hu, Yongai Li, Jun Zhao

Connect to this object online.

Neurological Adverse Events Related to Immune Checkpoint Inhibitors: A Practical Review by François Zammit, Emmanuel Seront

Connect to this object online.

Safety of COVID-19 vaccines in subjects with solid tumor cancers receiving immune checkpoint inhibitors by Danielle Gilbert, Junxiao Hu, Theresa Medina, Elizabeth R. Kessler, Elaine T. Lam

Connect to this object online.

Biomarkers and risk factors for the early prediction of immune-related adverse events: a review by Ying Zhang, Xiaoling Zhang, Weiling Li, Yunyi Du, Wenqing Hu, Jun Zhao

Connect to this object online.

Predictors of response to immune checkpoint inhibition in a real world gynecologic cancer population by Michelle L. Kuznicki, Carrie Bennett, Meng Yao, Amy Joehlin-Price, Peter G. Rose, Haider Mahdi

Connect to this object online.

Rheumatic immune-related adverse events associated with immune checkpoint inhibitors compared with placebo in oncologic patients: a systemic review and meta-analysis by Shuo Zhang, Ziyue Zhou, Li Wang, Mengtao Li, Fengchun Zhang, Xiaofeng Zeng

Connect to this object online.

The association between aspirin use and immune-related adverse events in specific cancer patients receiving ICIs therapy: analysis of the FAERS database by Huaju Yang, Zheran Liu, Ruidan Li, Rendong Huang, Xingchen Peng

Connect to this object online.

Tumor PD-L1 expression and molecular profiling are not associated with immune checkpoint inhibitor-induced thyroid dysfunction in advanced NSCLC patients by Adi Horesh, Rena Pollack, Rena Pollack, Hovav Nechushtan, Hovav Nechushtan, Rivka Dresner-Pollak, Rivka Dresner-Pollak, Tzahi Neuman, Tzahi Neuman

Connect to this object online.

The safety concerns regarding immune checkpoint inhibitors in liver cancer patients rising mainly from CHB by Shike Lou, Zhujun Cao, Wanqing Chi, Xiaoyin Wang, Mingyang Feng, Lanyi Lin, Yezhou Ding, Kehui Liu, Lihong Qu, Gangde Zhao, Shisan Bao, Hui Wang

Connect to this object online.

Immune-Related Adverse Events Associated with Anti-PD-1/PD-L1 Treatment for Malignancies: A Meta-Analysis by Peng-Fei Wang, Yang Chen, Yang Chen, Si-Ying Song, Ting-Jian Wang, Wen-Jun Ji, Shou-Wei Li, Ning Liu, Chang-Xiang Yan

Connect to this object online.

Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Advanced Non-small Cell Lung Cancer: A Network Meta-Analysis of Randomized Clinical Trials by Weidong Zhang, Jingjing Gu, Chunming Bian, Guanhong Huang

Connect to this object online.